Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Biomed Research International|July 7, 2022
Immune Infiltration Represents Potential Diagnostic and Prognostic Biomarkers for Esophageal Squamous Cell CarcinomaMengxiang Li, Pan Chen, Yuanji Zhao, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|April 23, 2014
Microarray expression profile analysis of long non-coding RNAs in human gastric cardiac adenocarcinomaYing Wang, Shegan Gao, Gang Liu, et al.
Photodiagnosis and Photodynamic Therapy|February 2, 2016
Specific cellular accumulation of photofrin-II in EC cells promotes photodynamic treatment efficacy in esophageal cancerShegan Gao, Shuo Liang, Kaili Ding, et al.
Hepato-Gastroenterology|March 18, 2014
Meta-analysis of two types of digestive tract reconstruction modes after total gastrectomyGongping Wang, Guangwei Ceng, Bo Zhou, et al.
Experimental Cell Research|December 27, 2019
miR-200b/c-RAP1B axis represses tumorigenesis and malignant progression of papillary thyroid carcinoma through inhibiting the NF-κB/Twist1 pathwayBo Zhou, Jing Xu, Ye Chen, et al.
Plos One|July 19, 2016
Immunohistochemical Determination of p53 Protein Overexpression for Predicting p53 Gene Mutations in Hepatocellular Carcinoma: A Meta-AnalysisJiangbo Liu, Wei Li, Miao Deng, et al.
Oncotarget|April 18, 2018
Polymorphisms in BER genes and risk of breast cancer: evidences from 69 studies with 33760 cases and 33252 controlsLele Qiao, Xiaoshan Feng, Gongping Wang, et al.
Cell & Bioscience|June 20, 2020
MicroRNA-320d regulates tumor growth and invasion by promoting FoxM1 and predicts poor outcome in gastric cardiac adenocarcinomaXiaojie Chen, Shegan Gao, Zhiwei Zhao, et al.
Oncotarget|October 1, 2015
Efficacy and safety of capecitabine-based first-line chemotherapy in advanced or metastatic breast cancer: a meta-analysis of randomised controlled trialsWeijiao Yin, Guangsheng Pei, Gang Liu, et al.
Molecular Medicine Reports|July 25, 2012
The Chk1 inhibitor AZD7762 sensitises p53 mutant breast cancer cells to radiation in vitro and in vivoZhikun Ma, Guoliang Yao, Bo Zhou, et al.
Pageof 6